The 99 Technologies' project started out in 1999 as a philanthropic initiative with the aim of funding broad research in the field of nosocomial infections' prevention.


The results have generated a cutting-edge technology which represents a very effective and efficient contribution to the fight against nosocomial infections and microbial load control practices in general.


The company is located in Lugano, Switzerland, and it is currently marketing internationally the disinfection system derived from the 99T’s technology. 

The highly innovative nature of the technology and the solid business planning associated to the 99 Technologies' project has attracted a highly diversified pool of investors. 


Among them the local government of the Swiss Canton of Ticino through Agire Invest of the Agire Foundation, the Sator Private Equity Fund, and Sagittario SpA.


Sagittario SpA is a financial company with prevailing investments in high tech companies operating worldwide.  



Agire Invest SA is responsible for selecting and financing the creation and development of start-ups and innovative projects for the Swiss Canton of Ticino. 

Our Corporate Responsibility

In our daily strive to reduce the burden of Health Care Acquired Infections we partner with non profit organizations active in helping financially challenged institutions. Learn how in the CSR dedicated section of our website.


If you have a solid experience in the marketing of new products and introducing novel technologies, you might be the person/organization we wish to have on our side as a distributor in your country. Please visit the Distributors' section of our website by clicking on the little yellow button below on the right to learn more.

Contact Us

If you have an immediate question you wish to ask us, please click on the yellow button below to the right, and fill out the short form.